BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22209340)

  • 1. Immunohistochemical expression profile of β-catenin, E-cadherin, P-cadherin, laminin-5γ2 chain, and SMAD4 in colorectal serrated adenocarcinoma.
    García-Solano J; Conesa-Zamora P; Trujillo-Santos J; Torres-Moreno D; Mäkinen MJ; Pérez-Guillermo M
    Hum Pathol; 2012 Jul; 43(7):1094-102. PubMed ID: 22209340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
    Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.
    Kamposioras K; Konstantara A; Kotoula V; Lakis S; Kouvatseas G; Akriviadis E; Vrettou E; Dionysopoulos D; Krikelis D; Papadopoulou K; Charalambous E; Chrisafi S; Konstantaras C; Fountzilas G
    Anticancer Res; 2013 Oct; 33(10):4573-84. PubMed ID: 24123033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-cadherin and β-catenin expression in canine colorectal adenocarcinoma.
    Aresu L; Pregel P; Zanetti R; Caliari D; Biolatti B; Castagnaro M
    Res Vet Sci; 2010 Dec; 89(3):409-14. PubMed ID: 20457460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
    Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
    Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of E-cadherin and catenins in sporadic colorectal carcinoma.
    El-Bahrawy MA; Poulsom R; Jeffery R; Talbot I; Alison MR
    Hum Pathol; 2001 Nov; 32(11):1216-24. PubMed ID: 11727261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of beta-catenin, alpha-catenin, and E-cadherin in Barrett's esophagus and esophageal adenocarcinomas.
    Washington K; Chiappori A; Hamilton K; Shyr Y; Blanke C; Johnson D; Sawyers J; Beauchamp D
    Mod Pathol; 1998 Sep; 11(9):805-13. PubMed ID: 9758359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tumor cell dissociation as a predictive marker of lymph node metastasis in submucosal invasive colorectal carcinoma.
    Hori H; Fujimori T; Fujii S; Ichikawa K; Ohkura Y; Tomita S; Ono Y; Imura J; Kuroda Y
    Dis Colon Rectum; 2005 May; 48(5):938-45. PubMed ID: 15785891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of alpha- and beta-catenin and E-cadherin expression in colorectal adenomas and carcinomas.
    van der Wurff AA; Vermeulen SJ; van der Linden EP; Mareel MM; Bosman FT; Arends JW
    J Pathol; 1997 Jul; 182(3):325-30. PubMed ID: 9349236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer.
    Boo YJ; Park JM; Kim J; Chae YS; Min BW; Um JW; Moon HY
    Ann Surg Oncol; 2007 May; 14(5):1703-11. PubMed ID: 17211730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-catenin and E-cadherin expression patterns in high-grade endometrial carcinoma are associated with histological subtype.
    Schlosshauer PW; Ellenson LH; Soslow RA
    Mod Pathol; 2002 Oct; 15(10):1032-7. PubMed ID: 12379748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas.
    Reinacher-Schick A; Baldus SE; Romdhana B; Landsberg S; Zapatka M; Mönig SP; Hölscher AH; Dienes HP; Schmiegel W; Schwarte-Waldhoff I
    J Pathol; 2004 Apr; 202(4):412-20. PubMed ID: 15095268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum response factor enhances liver metastasis of colorectal carcinoma via alteration of the E-cadherin/beta-catenin complex.
    Choi HN; Kim KR; Lee JH; Park HS; Jang KY; Chung MJ; Hwang SE; Yu HC; Moon WS
    Oncol Rep; 2009 Jan; 21(1):57-63. PubMed ID: 19082443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined loss of E-cadherin and aberrant β-catenin protein expression correlates with a poor prognosis for small intestinal adenocarcinomas.
    Lee HJ; Lee OJ; Jang KT; Bae YK; Chung JY; Eom DW; Kim JM; Yu E; Hong SM
    Am J Clin Pathol; 2013 Feb; 139(2):167-76. PubMed ID: 23355201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Smad4, E-cadherin and beta-catenin in advanced colorectal cancer: a retrospective study.
    Diab A; Nikolopoulou-Stamati P; Katostaras T; Safioleas M; Kostakis A; Athanassiadou P; Liossi-Ioakeim A; Marinos G; Konstantopoulos K
    J BUON; 2012; 17(1):92-6. PubMed ID: 22517699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomas.
    Norwood MG; Bailey N; Nanji M; Gillies RS; Nicholson A; Ubhi S; Darnton JJ; Steyn RS; Womack C; Hughes A; Hemingway D; Harrison R; Waters R; Jankowski JA
    Histopathology; 2010 Jul; 57(1):101-11. PubMed ID: 20572881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas.
    Sarrió D; Moreno-Bueno G; Sánchez-Estévez C; Bañón-Rodríguez I; Hernández-Cortés G; Hardisson D; Palacios J
    Hum Pathol; 2006 Aug; 37(8):1042-9. PubMed ID: 16867867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical alpha- and beta-catenin and E-cadherin expression and their clinicopathological significance in human lung adenocarcinoma.
    Nozawa N; Hashimoto S; Nakashima Y; Matsuo Y; Koga T; Sugio K; Niho Y; Harada M; Sueishi K
    Pathol Res Pract; 2006; 202(9):639-50. PubMed ID: 16843618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered distribution of beta-catenin and prognostic roles in colorectal carcinogenesis.
    Chen S; Liu J; Li G; Mo F; Xu X; Zhang T; Zhang X; Li J; Han X; Sun Y
    Scand J Gastroenterol; 2008; 43(4):456-64. PubMed ID: 18365911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L1, β-catenin, and E-cadherin expression in patients with colorectal cancer: correlation with clinicopathologic features and its prognostic significance.
    Fang QX; Lü LZ; Yang B; Zhao ZS; Wu Y; Zheng XC
    J Surg Oncol; 2010 Oct; 102(5):433-42. PubMed ID: 20672319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.